Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Karin Mirzaev"'
Autor:
Eric Rytkin, Kseniia Kriukova, Natalia Denisenko, Dmitriy Ivashchenko, Michael Zastrozhin, Karin Mirzaev, Dmitry Sychev
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/80dfa98462904d3a978b90ebdd4619ac
Autor:
Svetlana Serebrova, Daria Kurguzova, Lyudmila Krasnykh, Galina Vasilenko, Vladimir Drozdov, Natalia Lazareva, Eugenia Shikh, Marina Zhuravleva, Svetlana Rykova, Natalia Eremenko, Elena Kareva, Karin Mirzaev, Dmitriy Sychev, Alexey Prokofiev
Publikováno v:
Drug Metabolism and Personalized Therapy. 37:383-391
Objectives A comparative dissolution kinetics test (CDKT) and bioequivalence studies of generic proton pump inhibitors (PPIs) do not model pharmacological acid suppression (PAS) and pathological duodenogastric reflux (PDGR). This study aimed to model
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::caa8f4461eb04ca2c8e0f368f8efd7cc
https://doi.org/10.1515/dmpt-2021-0193
https://doi.org/10.1515/dmpt-2021-0193
Autor:
Olga Baturina, Denis Andreev, Ludmila Fedina, Karin Mirzaev, Dmitriy Ivashchenko, Kristina Ryzhikova, Elena Grishina, Pavel Bochkov, Roman Shevchenko, Dmitriy Sychev
Publikováno v:
Pharmacology. 107:216-226
Introduction: The interindividual variability of the antiplatelet effect of clopidogrel is determined by multiple clinical and genetic factors. A lot of genotype-oriented studies have concentrated on the impact of CYP2C19 gene polymorphisms on platel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c78a058897780805127a1a5bdb9571a9
https://doi.org/10.1159/000521531
https://doi.org/10.1159/000521531
Autor:
Dmitry Sychev, Ludmila Fedina, Maria Poptsova, Dmitry Zateyshchikov, Karin Mirzaev, Evgeny Tsimbal, Igor Sychev, Tatiana Rastvorova
Publikováno v:
Pharmacogenomics. 23(15)
Aims: To study the readiness of Russian physicians with experience and younger physicians undergoing clinical residency and postgraduate education to apply pharmacogenetic testing in their clinical practice. Materials & methods: The sociological stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a6aa654642d5222e5202b952a5401a5
https://pubmed.ncbi.nlm.nih.gov/36093937
https://pubmed.ncbi.nlm.nih.gov/36093937
Autor:
Dmitry Sychev, Olga Ostroumova, Marina Cherniaeva, Nataliia Shakhgildian, Karin Mirzaev, Sherzod Abdullaev, Natalia Denisenko, Zhannet Sozaeva, Anastasia Kachanova, Svetlana Gorbatenkova, Vera Shastina
Publikováno v:
High blood pressurecardiovascular prevention : the official journal of the Italian Society of Hypertension. 29(5)
ABCB1 gene polymorphisms are associated with rivaroxaban distribution changes and adverse reactions but the data are controversial.To evaluate the influence of ABCB1 (rs1045642 and rs4148738) gene polymorphisms on rivaroxaban pharmacokinetics in pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bc98d19a83ca49acbbad49634dc8dec
https://pubmed.ncbi.nlm.nih.gov/35960493
https://pubmed.ncbi.nlm.nih.gov/35960493
Autor:
Eric Rytkin, Karin Mirzaev, Irina Bure, Kristina Akmalova, Sherzod Abdullaev, Anastasia Kachanova, Valeriy Smirnov, Elena Grishina, Natalia Lyakhova, Elena Aleshkovich, Anna Saribekian, Denis Andreev, Alexey Shabunin, Dmitry Sychev
Publikováno v:
JACC: Cardiovascular Interventions. 16:S14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdf865973eb9dd4913b53623448fbef1
https://doi.org/10.1016/j.jcin.2023.01.062
https://doi.org/10.1016/j.jcin.2023.01.062
Autor:
Svetlana, Serebrova, Daria, Kurguzova, Lyudmila, Krasnykh, Galina, Vasilenko, Vladimir, Drozdov, Natalia, Lazareva, Eugenia, Shikh, Marina, Zhuravleva, Svetlana, Rykova, Natalia, Eremenko, Elena, Kareva, Karin, Mirzaev, Dmitriy, Sychev, Alexey, Prokofiev
Publikováno v:
Drug metabolism and personalized therapyReferences. 37(4)
A comparative dissolution kinetics test (CDKT) and bioequivalence studies of generic proton pump inhibitors (PPIs) do not model pharmacological acid suppression (PAS) and pathological duodenogastric reflux (PDGR). This study aimed to model them in CD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d1e13b3e3f6f2b2952b20513d8401293
https://pubmed.ncbi.nlm.nih.gov/36027921
https://pubmed.ncbi.nlm.nih.gov/36027921